Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 3
1991 9
1992 17
1993 35
1994 48
1995 71
1996 85
1997 92
1998 86
1999 94
2000 88
2001 104
2002 99
2003 101
2004 115
2005 96
2006 115
2007 100
2008 91
2009 87
2010 81
2011 104
2012 103
2013 105
2014 83
2015 105
2016 65
2017 93
2018 60
2019 84
2020 47
Text availability
Article attribute
Article type
Publication date

Search Results

2,298 results
Results by year
Filters applied: . Clear all
Page 1
RPS27a enhances EBV-encoded LMP1-mediated proliferation and invasion by stabilizing of LMP1.
Hong SW, Kim SM, Jin DH, Kim YS, Hur DY. Hong SW, et al. Biochem Biophys Res Commun. 2017 Sep 16;491(2):303-309. doi: 10.1016/j.bbrc.2017.07.105. Epub 2017 Jul 20. Biochem Biophys Res Commun. 2017. PMID: 28735865
Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP1) is an oncoviral protein that plays a pivotal role in EBV-induced oncogenic transformation. ...These results suggest that RSP27a could be a potential target in EBV-infected LMP1-po …
Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP1) is an oncoviral protein that plays a pivotal role in EBV
LMP1 and Dynamic Progressive Telomere Dysfunction: A Major Culprit in EBV-Associated Hodgkin's Lymphoma.
Knecht H, Mai S. Knecht H, et al. Viruses. 2017 Jun 27;9(7):164. doi: 10.3390/v9070164. Viruses. 2017. PMID: 28654015 Free PMC article. Review.
Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP1) is expressed in germinal-center-derived, mononuclear Hodgkin (H) and multinuclear, diagnostic Reed-Sternberg (RS) cells in classical EBV-positive Hodgkin's lymphoma (cHL). LMP1 expressio …
Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP1) is expressed in germinal-center-derived, mononuclear Hodgkin …
The Latent Membrane Protein 1 (LMP1).
Kieser A, Sterz KR. Kieser A, et al. Curr Top Microbiol Immunol. 2015;391:119-49. doi: 10.1007/978-3-319-22834-1_4. Curr Top Microbiol Immunol. 2015. PMID: 26428373 Review.
Almost exactly twenty years after the discovery of Epstein-Barr virus (EBV), the latent membrane protein 1 (LMP1) entered the EBV stage, and soon thereafter, it was recognized as the primary transforming gene product of the virus. LMP1 is expressed in …
Almost exactly twenty years after the discovery of Epstein-Barr virus (EBV), the latent membrane protein 1 (LMP1) entered the …
EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine.
Gupta S, Termini JM, Niu L, Kanagavelu SK, Schmidtmayerova H, Snarsky V, Kornbluth RS, Stone GW. Gupta S, et al. J Leukoc Biol. 2011 Aug;90(2):389-98. doi: 10.1189/jlb.0211068. Epub 2011 May 17. J Leukoc Biol. 2011. PMID: 21586676 Free PMC article.
In contrast, EBV induces robust T cell responses in most infected individuals, perhaps as this virus contains LMP1, a viral mimic of CD40, which is a key activating molecule for DCs and macrophages. Consequently, studies were conducted using LMP1 and LMP1
In contrast, EBV induces robust T cell responses in most infected individuals, perhaps as this virus contains LMP1, a viral mi …
The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC).
Dawson CW, Port RJ, Young LS. Dawson CW, et al. Semin Cancer Biol. 2012 Apr;22(2):144-53. doi: 10.1016/j.semcancer.2012.01.004. Epub 2012 Jan 12. Semin Cancer Biol. 2012. PMID: 22249143 Review.
Although frequently expressed in EBV-positive malignancies, the contribution of the oncogenic latent membrane proteins, LMP1 and LMP2, to the pathogenesis of nasopharyngeal carcinoma (NPC) is not fully defined. As a key effector in EBV-driven B cell transform …
Although frequently expressed in EBV-positive malignancies, the contribution of the oncogenic latent membrane proteins, LMP1 a …
Expression of EBV-encoded oncogenes and EBV-like virions in multiple canine tumors.
Chiu HC, Chow KC, Fan YH, Chang SC, Chiou SH, Chiang SF, Chiou CH, Wu GH, Yang HC, Ho SP, Chen YK, Lee WC, Sun HS. Chiu HC, et al. Vet Microbiol. 2013 Apr 12;163(1-2):79-89. doi: 10.1016/j.vetmic.2012.12.022. Epub 2013 Jan 14. Vet Microbiol. 2013. PMID: 23380461
A novel LMP1 variant, T0905, was predominant in 5 canine tumor specimens and found to exist in EBV positive human BC-2 cells. ...The identity of BHRF1 and the resemblance of LMP1 variants between canine and human tumors indicate either a close e …
A novel LMP1 variant, T0905, was predominant in 5 canine tumor specimens and found to exist in EBV positive human BC-2 …
Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity.
Saechan V, Mori A, Mitarnun W, Settheetham-Ishida W, Ishida T. Saechan V, et al. J Clin Virol. 2006 Jun;36(2):119-25. doi: 10.1016/j.jcv.2006.01.018. Epub 2006 Apr 17. J Clin Virol. 2006. PMID: 16616610
In Thailand, the EBV genome is frequently detected in circulating T cells of T-cell diseases. OBJECTIVE: To determine the role of EBV LMP1 variation in the genesis of T-cell diseases, we focused on virus factors and analyzed EBV strains in Thailand. .. …
In Thailand, the EBV genome is frequently detected in circulating T cells of T-cell diseases. OBJECTIVE: To determine the role of …
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1.
Hulse M, Caruso LB, Madzo J, Tan Y, Johnson S, Tempera I. Hulse M, et al. PLoS Pathog. 2018 Nov 5;14(11):e1007394. doi: 10.1371/journal.ppat.1007394. eCollection 2018 Nov. PLoS Pathog. 2018. PMID: 30395643 Free PMC article.
Latent membrane protein 1 (LMP1) is the major transforming protein of Epstein-Barr virus (EBV) and is critical for EBV-induced B-cell transformation in vitro. ...Finally, LMP1+ cells are more sensitive to PARP1 inhibition and, therefore, targeting PARP …
Latent membrane protein 1 (LMP1) is the major transforming protein of Epstein-Barr virus (EBV) and is critical for EBV- …
Transmembrane Domains Mediate Intra- and Extracellular Trafficking of Epstein-Barr Virus Latent Membrane Protein 1.
Nkosi D, Howell LA, Cheerathodi MR, Hurwitz SN, Tremblay DC, Liu X, Meckes DG Jr. Nkosi D, et al. J Virol. 2018 Aug 16;92(17):e00280-18. doi: 10.1128/JVI.00280-18. Print 2018 Sep 1. J Virol. 2018. PMID: 29950415 Free PMC article.
EBV latent membrane protein 1 (LMP1) is released from latently infected tumor cells in small membrane-enclosed extracellular vesicles (EVs). ...LMP1 is an important viral protein expressed by EBV in these cancers. LMP1 is secreted in extracellul
EBV latent membrane protein 1 (LMP1) is released from latently infected tumor cells in small membrane-enclosed extracellular v
Epstein-Barr virus (EBV)-associated lymphoid lesions of the head and neck.
Auerbach A, Aguilera NS. Auerbach A, et al. Semin Diagn Pathol. 2015 Jan;32(1):12-22. doi: 10.1053/j.semdp.2014.12.001. Epub 2015 Feb 7. Semin Diagn Pathol. 2015. PMID: 25804341 Review.
EBV is the first virus linked to malignancies, both epithelial and lymphoid. Both T and B cell lymphomas can be associated with EBV and evidence shows that an individual's response to the acute EBV infection may be critical in the development of subsequent ly
EBV is the first virus linked to malignancies, both epithelial and lymphoid. Both T and B cell lymphomas can be associated with EB
2,298 results
Jump to page
Feedback